Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of mesenchymal stem cell derived bio-pharmaceuticals. The company develops mesenchymal stem cell derived bio-pharmaceuticals to treat inflammatory and degenerative ophthalmic diseases.
You’re viewing a free company profile from the PitchBook Platform. To explore Cell Care Therapeutics’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.